Selected Publications

Kimberley T Lee, Melanie Buhlmann, Clement K Gwede, L. Robert Gore, I-Wen Pan, Yi Luo, Shelley S Tworoger, Susan Thomas Vadaparampil, and Heather S.L. Jim.: Impact of endocrine therapy adherence on racial disparities in breast cancer survival. Journal of Clinical Oncology 2023 41:16_suppl, 541-541. American Society of Clinical Oncology Annual Meeting, Chicago, Il. Jun 2023 Notes: "Oral Presentation"

Ricardo L Costa, Jennifer A Childress, Edith Abraham, Carly Farrell, Qianxing Mo, Zena Jameel, Aixa Elena Soyano Muller, Kimberley T Lee, Susan Hoover, John Kiluk, Robert J Weinfurtner, Marie Catherine Lee, Christine Laronga, Nazanin Khakpour, Hyo S. Han, Hung T. Khong, Hatem Hussein Soliman, Brian J. Czerniecki.: Phase 1 dose-escalation, dose-expansion trial of intratumoral HER2- and HER3-primed dendritic cells injections for the treatment of early-stage TNBC and HR low positive breast cancer: DecipHER trial. American Society of Clinical Oncology Annual Meeting, Chicago, IL. Jun 2023 Notes: "Poster Presentation"

Hyo S. Han, Ricardo L Costa, Hatem Hussein Soliman, Aixa Soyano, Hung T. Khong, Loretta S. Loftus, Kimberley T Lee, Avan J. Armaghani, Hien Liu, Jessica Malka, Frederick L. Locke, Qianxing Mo, Junmin Whiting, Lavakumar Karyampudi, Elizabeth E. Evans, Terrence Lee Fisher, Maurice Zauderer, Brian J. Czerniecki, : Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC). American Society of Clinical Oncology Annual Meeting, Chicago, IL. Jun 2023 Notes: "Poster Presentation"

Sheffield KM, Peachey JR, Method M, Grimes BR, Brown J, Saverno K, Sugihara T, Lin Cui Z, Lee KT.: A Real World US Study of Recurrence Risks using Combined Clinicopathologic Features in HR+, HER2- Early Breast Cancer. Future Oncol 18(21): 2667-2682. Jul 2022.

Lee, KT.: “Racial Disparities in Breast Cancer.” American Society of Clinical Oncology Annual Meeting, Chicago, IL. Jun 2022 Notes: "Poster Presentation"

Islam JY, Hathaway C, Lee KT, Hume E, Turner K, Hallanger-Johnson JE, Tworoger S, Camacho-Rivera M. : Racial/ethnic disparities of cancer treatment disruptions among patients with breast cancer with SARS-CoV-2 infection: An analysis of the ASCO Survey on COVID-19 in Oncology Registry. American Society of Clinical Oncology Annual Meeting, Chicago, IL, Jun 2022 Notes: "Poster Presentation"

Haval N, Lee KT, Alcorn D, Mangini N, Stearns V.: Incidence and severity of myelosuppression with palbociclib after palliative bone radiation in advanced breast cancer: A single center experience and review of literature. Clin Breast Cancer 22(1): e65-e73. Jan 2022.

Unknown: Speaker, Moffitt Cancer Center Breast Cancer Awareness Month Webinar Series. “Breast Cancer 101.” \{Unknown} 2022.

Fulton HJ, Charles DR, Geiss C, Gonzalez B, Jim H, Gwede C, Tworoger S, Lee KT. : Barriers to use of adjuvant endocrine therapy among Black women with breast cancer: A qualitative investigation. American Association of Cancer Research Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Undeserved, Philadelphia PA. 2022 Notes: "Poster Presentation"

Unknown: Speaker, Moffitt Breast dinner community program. “Closing the gap in breast cancer disparities.” \{Unknown} 2022.